|    editor@medjpps.com

www.medjpps.com

Received date : 06-02-2021 Revised date : 14-02-2021 Accepted date : 16-02-2021 Published date : 31-03-2021

Mediterr J Pharm Pharm Sci 1 (1): 5-11, 2021

DOI: https://doi.org/10.5281/zenodo.5171379

Review


Precision medicine: recent progress in cancer therapy

Phalguna Yadagiri, Prakash Katakam, Shaban G. Elosta, Shanta Kumari Adiki


Abstract
This review was aimed to describe a new approach of healthcare performance strategy based on individual genetic variants. Personalized medicine is a model for health care that is a combination of preventive, personalized, participatory, and predictive measures. It is an approach for better treatment by identifying the disease-causing genomics makeup of an individual. This work features key advancements in the improvement of empowering advances that further the objective of customized and precision medication and the remaining difficulties that, when tended to, may produce phenomenal abilities in acknowledging genuinely individualized patient consideration. Customized treatment for patients determined to have strong tumors has brought about a few advances as of late. To improve a multi-drug approach ready to coordinate DNA and RNA adjustment, proteomics and metabolomics will be essential. The execution of translational examinations dependent on fluid biopsy and organoids or xenografts to assess molecular changes because of clonal weight produced because of the utilization of target specialists or tumor heterogeneity would help in the recognition of systems of opposition, proposing opportunities for novel mixes. The investigation of massive data in oncology can profit altogether from being engaged by artificial intelligence and machine learning strategies.
Share :